A chronic disease becomes treatable: First drug against hepatitis D approved


Prof. Dr. Stephan Urban (left) and Prof. Dr. Ralf Bartenschlager from the Department of Molecular Virology at the Centre for Infectiology at the UKHD have been working for years to improve the diagnosis and therapy of hepatitis virus infections.



What started as basic research around 25 years ago has now led to the successful approval of a drug: Hepcludex has been approved by the European Commission for the treatment of chronic hepatitis D infections.

This is a successful example of translation from basic research to application in Heidelberg.


Complete News (in German).